Concepts (104)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lipoprotein(a) | 5 | 2024 | 435 | 1.440 |
Why?
|
Atherosclerosis | 6 | 2024 | 3445 | 1.160 |
Why?
|
Hypolipidemic Agents | 2 | 2020 | 604 | 1.030 |
Why?
|
Cardiovascular Diseases | 9 | 2024 | 15165 | 0.970 |
Why?
|
Myocardial Infarction | 9 | 2022 | 11727 | 0.810 |
Why?
|
Lifting | 1 | 2022 | 56 | 0.800 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2023 | 859 | 0.620 |
Why?
|
Natural Language Processing | 3 | 2024 | 1041 | 0.610 |
Why?
|
Diffusion of Innovation | 1 | 2022 | 725 | 0.590 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2023 | 1265 | 0.490 |
Why?
|
Registries | 7 | 2022 | 8089 | 0.440 |
Why?
|
Dyslipidemias | 1 | 2019 | 849 | 0.410 |
Why?
|
Cholesterol, LDL | 2 | 2021 | 2356 | 0.380 |
Why?
|
Coronary Vessels | 2 | 2021 | 3107 | 0.330 |
Why?
|
Coronary Angiography | 2 | 2020 | 4577 | 0.320 |
Why?
|
Calcium | 2 | 2021 | 5756 | 0.300 |
Why?
|
Decision Making | 1 | 2019 | 3887 | 0.260 |
Why?
|
Biomedical Research | 1 | 2020 | 3309 | 0.250 |
Why?
|
Risk Assessment | 5 | 2024 | 23338 | 0.240 |
Why?
|
Delivery of Health Care | 1 | 2022 | 5319 | 0.240 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7279 | 0.210 |
Why?
|
Calcinosis | 2 | 2021 | 1499 | 0.200 |
Why?
|
Risk Factors | 11 | 2024 | 72290 | 0.190 |
Why?
|
Ventricular Function, Left | 2 | 2023 | 3670 | 0.170 |
Why?
|
Aortic Valve Stenosis | 2 | 2021 | 1965 | 0.160 |
Why?
|
Preventive Medicine | 1 | 2019 | 264 | 0.150 |
Why?
|
Cardiology Service, Hospital | 1 | 2019 | 246 | 0.150 |
Why?
|
Myocardial Revascularization | 1 | 2021 | 841 | 0.150 |
Why?
|
Comorbidity | 2 | 2021 | 10388 | 0.140 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2024 | 3255 | 0.140 |
Why?
|
Influenza Vaccines | 1 | 2023 | 738 | 0.140 |
Why?
|
Medically Uninsured | 1 | 2021 | 853 | 0.130 |
Why?
|
Humans | 24 | 2024 | 744343 | 0.120 |
Why?
|
Age of Onset | 1 | 2021 | 3271 | 0.120 |
Why?
|
Atrial Fibrillation | 2 | 2023 | 5034 | 0.120 |
Why?
|
Echocardiography | 2 | 2023 | 5102 | 0.120 |
Why?
|
Defibrillators, Implantable | 1 | 2023 | 1440 | 0.120 |
Why?
|
Death, Sudden, Cardiac | 1 | 2022 | 1541 | 0.110 |
Why?
|
Mortality | 2 | 2021 | 2864 | 0.110 |
Why?
|
Influenza, Human | 1 | 2023 | 1479 | 0.110 |
Why?
|
Patient Admission | 1 | 2019 | 1380 | 0.100 |
Why?
|
Coronary Artery Disease | 2 | 2021 | 6487 | 0.100 |
Why?
|
Stroke Volume | 2 | 2023 | 5007 | 0.100 |
Why?
|
Cause of Death | 1 | 2021 | 3584 | 0.090 |
Why?
|
Proportional Hazards Models | 2 | 2022 | 12354 | 0.090 |
Why?
|
Recovery of Function | 1 | 2020 | 2925 | 0.090 |
Why?
|
Retrospective Studies | 6 | 2024 | 77449 | 0.080 |
Why?
|
Academic Medical Centers | 1 | 2019 | 2759 | 0.080 |
Why?
|
Insurance, Health | 1 | 2021 | 2494 | 0.080 |
Why?
|
Stroke | 2 | 2022 | 9981 | 0.080 |
Why?
|
Smoking Cessation | 1 | 2020 | 2071 | 0.080 |
Why?
|
Sensitivity and Specificity | 1 | 2023 | 14722 | 0.080 |
Why?
|
Cardiology | 1 | 2019 | 1668 | 0.080 |
Why?
|
Massachusetts | 1 | 2020 | 8663 | 0.080 |
Why?
|
Socioeconomic Factors | 1 | 2021 | 7785 | 0.070 |
Why?
|
Heart Failure | 2 | 2022 | 10900 | 0.070 |
Why?
|
Survival Rate | 1 | 2020 | 12788 | 0.070 |
Why?
|
Incidence | 2 | 2020 | 20947 | 0.060 |
Why?
|
Brain Ischemia | 1 | 2019 | 3265 | 0.060 |
Why?
|
Substance-Related Disorders | 1 | 2021 | 4258 | 0.060 |
Why?
|
Electronic Health Records | 1 | 2021 | 4468 | 0.060 |
Why?
|
Coronary Disease | 1 | 2019 | 6077 | 0.060 |
Why?
|
Male | 11 | 2023 | 350118 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2019 | 3158 | 0.060 |
Why?
|
Female | 12 | 2023 | 380194 | 0.060 |
Why?
|
Middle Aged | 7 | 2022 | 213383 | 0.060 |
Why?
|
Young Adult | 4 | 2022 | 56430 | 0.060 |
Why?
|
Behavioral Risk Factor Surveillance System | 1 | 2023 | 199 | 0.060 |
Why?
|
Diabetes Mellitus | 1 | 2021 | 5751 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2019 | 5137 | 0.050 |
Why?
|
Follow-Up Studies | 2 | 2020 | 39050 | 0.050 |
Why?
|
Hypertension | 1 | 2021 | 8480 | 0.050 |
Why?
|
Algorithms | 1 | 2021 | 13881 | 0.050 |
Why?
|
Adult | 7 | 2023 | 214055 | 0.050 |
Why?
|
United States | 3 | 2023 | 69872 | 0.040 |
Why?
|
Phospholipids | 1 | 2021 | 784 | 0.040 |
Why?
|
Anticoagulants | 2 | 2023 | 4599 | 0.040 |
Why?
|
Shock, Cardiogenic | 1 | 2022 | 688 | 0.040 |
Why?
|
Warfarin | 1 | 2023 | 1496 | 0.030 |
Why?
|
Consensus | 1 | 2023 | 2959 | 0.030 |
Why?
|
Propensity Score | 1 | 2020 | 1781 | 0.030 |
Why?
|
Lipids | 1 | 2023 | 3305 | 0.030 |
Why?
|
Aortic Valve | 1 | 2021 | 1922 | 0.020 |
Why?
|
Vaccination | 1 | 2023 | 3278 | 0.020 |
Why?
|
Communication | 1 | 2024 | 3749 | 0.020 |
Why?
|
Software | 1 | 2024 | 4443 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2022 | 5317 | 0.020 |
Why?
|
Cohort Studies | 2 | 2022 | 40561 | 0.020 |
Why?
|
Inpatients | 1 | 2019 | 2518 | 0.020 |
Why?
|
Health Status Disparities | 1 | 2019 | 1797 | 0.020 |
Why?
|
Animals | 1 | 2019 | 168757 | 0.020 |
Why?
|
Sex Factors | 1 | 2020 | 10397 | 0.020 |
Why?
|
Boston | 1 | 2019 | 9313 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15076 | 0.020 |
Why?
|
Patient Readmission | 1 | 2019 | 3114 | 0.020 |
Why?
|
Prevalence | 1 | 2020 | 15226 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2020 | 63114 | 0.010 |
Why?
|
Smoking | 1 | 2020 | 8987 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2020 | 21746 | 0.010 |
Why?
|
Child, Preschool | 1 | 2022 | 41006 | 0.010 |
Why?
|
Aged | 2 | 2021 | 163280 | 0.010 |
Why?
|
Obesity | 1 | 2020 | 12745 | 0.010 |
Why?
|
Time Factors | 1 | 2019 | 40075 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2019 | 57776 | 0.010 |
Why?
|
Concepts
(104)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(93)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_